| Quarter | Score |
|---|---|
| 2013-Q2 | 49.5 |
| 2013-Q3 | 50.3 |
| 2013-Q4 | 49.1 |
| 2014-Q1 | 64.4 |
| 2014-Q2 | 56.5 |
| 2014-Q3 | 54.5 |
| 2018-Q1 | 48.0 |
| 2018-Q2 | 49.1 |
| 2018-Q3 | 48.7 |
| 2019-Q2 | 48.2 |
| 2022-Q1 | 49.3 |
| 2022-Q3 | 65.6 |
| 2022-Q4 | 49.3 |
| 2023-Q1 | 49.1 |
| 2023-Q2 | 36.0 |
| 2023-Q3 | 49.2 |
| 2023-Q4 | 42.5 |
| 2024-Q1 | 62.6 |
| 2024-Q2 | 59.1 |
| 2024-Q3 | 58.0 |
| 2024-Q4 | 62.5 |
| 2025-Q1 | 63.6 |
| 2025-Q2 | 68.9 |
| 2025-Q3 | 64.4 |
| 2025-Q4 | 66.1 |
| 2026-Q2 | 46.4 |
Stable institutional holding; maintain existing positions
Within 5.7% of funds' estimated purchase price
1 of 16 tracked funds hold GLNG. Avg conviction: 3.7%. Net adding. First tracked at $49.84 (current +5.7% vs tracked).
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Sachem Head Capital | 3.7% | New Buy |